Guo‐Wu Rao

2.1k total citations
130 papers, 1.7k citations indexed

About

Guo‐Wu Rao is a scholar working on Organic Chemistry, Molecular Biology and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, Guo‐Wu Rao has authored 130 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Organic Chemistry, 26 papers in Molecular Biology and 26 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in Guo‐Wu Rao's work include Click Chemistry and Applications (14 papers), Synthesis and Characterization of Heterocyclic Compounds (14 papers) and Nuclear physics research studies (12 papers). Guo‐Wu Rao is often cited by papers focused on Click Chemistry and Applications (14 papers), Synthesis and Characterization of Heterocyclic Compounds (14 papers) and Nuclear physics research studies (12 papers). Guo‐Wu Rao collaborates with scholars based in China, India and Belgium. Guo‐Wu Rao's co-authors include Wei‐Xiao Hu, Chenfu Liu, Quan Zheng, Jie Chen, H.S. Hans, Ranjit Singh, Deepti Gupta, Sai Sathish Ramamurthy, Ganji Seeta Rama Raju and Kang Cheng and has published in prestigious journals such as Physical review. B, Condensed matter, Journal of Applied Physics and The Science of The Total Environment.

In The Last Decade

Guo‐Wu Rao

123 papers receiving 1.6k citations

Peers

Guo‐Wu Rao

AMPO

CMP

NHEP

H. S. Peiser United States

C. E. Johnson United Kingdom

A. Williams United Kingdom

H. Grimm Germany

P. Bopp Germany

M. P. Klein United States

Congcong Huang China

Michael Meyer Germany

E. N. Maslen Australia

Félix Fernández-Alonso United Kingdom

H. S. Peiser United States

Guo‐Wu Rao

197 ×0.5

228 ×0.6

AMPO

121 ×0.5

CMP

141 ×0.6

152 ×0.7

NHEP

Citations per year, relative to Guo‐Wu Rao Guo‐Wu Rao (= 1×) peers H. S. Peiser

Countries citing papers authored by Guo‐Wu Rao

Since Specialization

Citations

This map shows the geographic impact of Guo‐Wu Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Wu Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Wu Rao more than expected).

Fields of papers citing papers by Guo‐Wu Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐Wu Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Wu Rao. The network helps show where Guo‐Wu Rao may publish in the future.

Co-authorship network of co-authors of Guo‐Wu Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Wu Rao. A scholar is included among the top collaborators of Guo‐Wu Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Wu Rao. Guo‐Wu Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Feng, Yu Wang, Haoran Xu, et al.. (2025). Advances in cancer immunotherapy using small-molecular inhibitors targeting the PD-1/PD-L1 interaction. Bioorganic & Medicinal Chemistry. 127. 118238–118238. 2 indexed citations

Hu, Haoqiang, Xiaowen Wu, Hong Wang, et al.. (2025). Optimized ebselen derivatives as novel potent Escherichia coli β-glucuronidase covalent allosteric inhibitors. European Journal of Medicinal Chemistry. 290. 117571–117571. 2 indexed citations

Zhang, Feng, Caiyun Wu, Yu Wang, et al.. (2024). Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction. Bioorganic & Medicinal Chemistry. 111. 117867–117867. 5 indexed citations

Ding, Lei, et al.. (2024). Summary and future of medicine for hereditary angioedema. Drug Discovery Today. 29(3). 103890–103890.

Li, Yingchun, Fang Zhou, Wen Zhang, Guo‐Wu Rao, & Quan Zheng. (2024). Targeting XPO1 for fighting relapsed/refractory diseases: The research progress of XPO1 inhibitors. Bioorganic Chemistry. 154. 108073–108073. 1 indexed citations

Liu, Chenfu, et al.. (2024). Current status of drugs targeting PDGF/PDGFR. Drug Discovery Today. 29(7). 103989–103989. 22 indexed citations

Liu, Chenfu, et al.. (2023). A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C). Current Medicinal Chemistry. 32(4). 647–677. 2 indexed citations

Zhang, Chengjie, Mingtao Zhao, Guo‐Wu Rao, et al.. (2023). A precise method to monitor hydroxyl radical in natural waters based on a fluoride-containing fluorescence probe. The Science of The Total Environment. 903. 166961–166961. 19 indexed citations

Cheng, Kang, Chenfu Liu, & Guo‐Wu Rao. (2020). Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors. Current Medicinal Chemistry. 28(13). 2540–2564. 37 indexed citations

10.

Li, Xiufang, Chenfu Liu, & Guo‐Wu Rao. (2020). Monoclonal Antibodies, Small Molecule Inhibitors and Antibody-drug Conjugates as HER2 Inhibitors. Current Medicinal Chemistry. 28(17). 3339–3360. 6 indexed citations

11.

Rao, Guo‐Wu, et al.. (2018). Crystal structure of 8-(trifluoromethyl)imidazo[1,2-a]pyridine-3-carbaldehyde, C₉H₅F₃N₂O. Zeitschrift für Kristallographie - New Crystal Structures. 233(6). 1081–1082.

12.

Rao, Guo‐Wu, et al.. (2013). Synthesis, Antitumor Evaluation and Docking Study of Novel 4‐Anilinoquinazoline Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors. ChemMedChem. 8(6). 928–933. 13 indexed citations

13.

Rao, Guo‐Wu, Cui Wang, Jian Wang, Zhen‐Guo Zhao, & Wei‐Xiao Hu. (2013). Synthesis, structure analysis, antitumor evaluation and 3D-QSAR studies of 3,6-disubstituted-dihydro-1,2,4,5-tetrazine derivatives. Bioorganic & Medicinal Chemistry Letters. 23(23). 6474–6480. 14 indexed citations

14.

Singh, Govind, et al.. (2013). 2-Bromo-3-hydroxy-6-methylpyridine. Acta Crystallographica Section E Structure Reports Online. 69(12). o1729–o1729. 1 indexed citations

15.

Rao, Guo‐Wu, et al.. (2012). Chemical Speciation Studies of Malonic Acid Complexes of Co(II), Cu(II), Ni(II) and Zn(II) in Dioxan-Water Mixtures. Der pharma chemica. 4(2). 655–663. 5 indexed citations

16.

Rao, Guo‐Wu & Wei‐Xiao Hu. (2006). Synthesis, structure analysis, and antitumor activity of 3,6-disubstituted-1,4-dihydro-1,2,4,5-tetrazine derivatives. Bioorganic & Medicinal Chemistry Letters. 16(14). 3702–3705. 59 indexed citations

17.

Rao, Guo‐Wu & Wei‐Xiao Hu. (2005). Synthesis, X-ray crystallographic analysis, and antitumor activity of 1-acyl-3,6-disubstituted phenyl-1,4-dihydro-1,2,4,5-tetrazines. Bioorganic & Medicinal Chemistry Letters. 15(12). 3174–3176. 28 indexed citations

18.

Hu, Wei‐Xiao, et al.. (2004). Synthesis and antitumor activity of s -tetrazine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(5). 1177–1181. 74 indexed citations

19.

Verma, H. C. & Guo‐Wu Rao. (1981). The electric field gradient at 57Fe in zinc and comparisons with the conduction-electron charge-shift model. Physics Letters A. 82(6). 303–305. 7 indexed citations

20.

Singhvi, A.K., Deepti Gupta, K. V. G. K. Gokhale, & Guo‐Wu Rao. (1974). Mössbauer spectra of ilmenites from primary and secondary sources. physica status solidi (a). 23(1). 321–324. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact